Exact Sciences Statistics
Total Valuation
Exact Sciences has a market cap or net worth of $11.23 billion. The enterprise value is $12.91 billion.
Important Dates
The next confirmed earnings date is Monday, November 3, 2025, after market close.
| Earnings Date | Nov 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Exact Sciences has 189.32 million shares outstanding. The number of shares has increased by 2.39% in one year.
| Current Share Class | 189.32M |
| Shares Outstanding | 189.32M |
| Shares Change (YoY) | +2.39% |
| Shares Change (QoQ) | +1.12% |
| Owned by Insiders (%) | 0.92% |
| Owned by Institutions (%) | 91.72% |
| Float | 187.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 83.08 |
| PS Ratio | 3.76 |
| Forward PS | 3.29 |
| PB Ratio | 4.55 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 66.21 |
| P/OCF Ratio | 36.75 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 164.90, with an EV/FCF ratio of 76.11.
| EV / Earnings | n/a |
| EV / Sales | 4.39 |
| EV / EBITDA | 164.90 |
| EV / EBIT | n/a |
| EV / FCF | 76.11 |
Financial Position
The company has a current ratio of 2.89, with a Debt / Equity ratio of 1.03.
| Current Ratio | 2.89 |
| Quick Ratio | 2.38 |
| Debt / Equity | 1.03 |
| Debt / EBITDA | 21.46 |
| Debt / FCF | 14.96 |
| Interest Coverage | -4.84 |
Financial Efficiency
Return on equity (ROE) is -35.51% and return on invested capital (ROIC) is -1.58%.
| Return on Equity (ROE) | -35.51% |
| Return on Assets (ROA) | -1.39% |
| Return on Invested Capital (ROIC) | -1.58% |
| Return on Capital Employed (ROCE) | -2.63% |
| Revenue Per Employee | $419,993 |
| Profits Per Employee | -$143,603 |
| Employee Count | 7,000 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 5.97 |
Taxes
| Income Tax | -9.22M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.34% in the last 52 weeks. The beta is 1.24, so Exact Sciences's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | -14.34% |
| 50-Day Moving Average | 50.21 |
| 200-Day Moving Average | 50.95 |
| Relative Strength Index (RSI) | 74.78 |
| Average Volume (20 Days) | 2,190,576 |
Short Selling Information
The latest short interest is 8.09 million, so 4.27% of the outstanding shares have been sold short.
| Short Interest | 8.09M |
| Short Previous Month | 7.34M |
| Short % of Shares Out | 4.27% |
| Short % of Float | 4.31% |
| Short Ratio (days to cover) | 2.76 |
Income Statement
In the last 12 months, Exact Sciences had revenue of $2.94 billion and -$1.01 billion in losses. Loss per share was -$5.40.
| Revenue | 2.94B |
| Gross Profit | 2.05B |
| Operating Income | -138.98M |
| Pretax Income | -1.01B |
| Net Income | -1.01B |
| EBITDA | 78.28M |
| EBIT | -138.98M |
| Loss Per Share | -$5.40 |
Full Income StatementBalance Sheet
The company has $858.44 million in cash and $2.54 billion in debt, giving a net cash position of -$1.68 billion or -$8.87 per share.
| Cash & Cash Equivalents | 858.44M |
| Total Debt | 2.54B |
| Net Cash | -1.68B |
| Net Cash Per Share | -$8.87 |
| Equity (Book Value) | 2.47B |
| Book Value Per Share | 13.05 |
| Working Capital | 985.93M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $305.61 million and capital expenditures -$135.99 million, giving a free cash flow of $169.62 million.
| Operating Cash Flow | 305.61M |
| Capital Expenditures | -135.99M |
| Free Cash Flow | 169.62M |
| FCF Per Share | $0.90 |
Full Cash Flow StatementMargins
Gross margin is 69.63%, with operating and profit margins of -4.73% and -34.19%.
| Gross Margin | 69.63% |
| Operating Margin | -4.73% |
| Pretax Margin | -34.51% |
| Profit Margin | -34.19% |
| EBITDA Margin | 2.66% |
| EBIT Margin | -4.73% |
| FCF Margin | 5.77% |
Dividends & Yields
Exact Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.39% |
| Shareholder Yield | n/a |
| Earnings Yield | -8.95% |
| FCF Yield | 1.51% |
Dividend DetailsAnalyst Forecast
The average price target for Exact Sciences is $68.52, which is 15.51% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $68.52 |
| Price Target Difference | 15.51% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 21 |
| Revenue Growth Forecast (5Y) | 10.43% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Exact Sciences has an Altman Z-Score of 1.37 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.37 |
| Piotroski F-Score | 5 |
